Key pathways as therapeutic targets
- PMID: 21921054
- DOI: 10.1182/blood-2011-07-362723
Key pathways as therapeutic targets
Comment on
-
Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.Blood. 2011 Sep 15;118(11):3080-7. doi: 10.1182/blood-2011-03-341412. Epub 2011 Jun 16. Blood. 2011. PMID: 21680795 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources

